Logo for BioXcel Therapeutics Inc

BioXcel Therapeutics Investor Relations Material

Latest events

Logo for BioXcel Therapeutics Inc

Q3 2024

BioXcel Therapeutics
Logo for BioXcel Therapeutics

Q3 2024

14 Nov, 2024
Logo for BioXcel Therapeutics

Q2 2024

6 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from BioXcel Therapeutics Inc

Access all reports
BioXcel Therapeutics, Inc. is a biopharmaceutical company focused on utilizing artificial intelligence to discover and develop new therapies in neuroscience and immuno-oncology. The company leverages its proprietary AI platform to identify and advance drug candidates for the treatment of complex conditions, including psychiatric disorders and cancers. BioXcel Therapeutics is engaged in both clinical and preclinical development. The company is headquartered in New Haven, United States, and its shares are listed on the NASDAQ.